Author:
Schupp Jonas Christian,Freitag-Wolf Sandra,Bargagli Elena,Mihailović-Vučinić Violeta,Rottoli Paola,Grubanovic Aleksandar,Müller Annegret,Jochens Arne,Tittmann Lukas,Schnerch Jasmin,Olivieri Carmela,Fischer Annegret,Jovanovic Dragana,Filipovic Snežana,Videnovic-Ivanovic Jelica,Bresser Paul,Jonkers René,O'Reilly Kate,Ho Ling-Pei,Gaede Karoline I.,Zabel Peter,Dubaniewicz Anna,Marshall Ben,Kieszko Robert,Milanowski Janusz,Günther Andreas,Weihrich Anette,Petrek Martin,Kolek Vitezslav,Keane Michael P.,O'Beirne Sarah,Donnelly Seamas,Haraldsdottir Sigridur Olina,Jorundsdottir Kristin B.,Costabel Ulrich,Bonella Francesco,Wallaert Benoît,Grah Christian,Peroš-Golubičić Tatjana,Luisetti Mauritio,Kadija Zamir,Pabst Stefan,Grohé Christian,Strausz János,Vašáková Martina,Sterclova Martina,Millar Ann,Homolka Jiří,Slováková Alena,Kendrick Yvonne,Crawshaw Anjali,Wuyts Wim,Spencer Lisa,Pfeifer Michael,Valeyre Dominique,Poletti Venerino,Wirtz Hubertus,Prasse Antje,Schreiber Stefan,Krawczak Michael,Müller-Quernheim Joachim
Abstract
Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology. The GenPhenReSa (Genotype–Phenotype Relationship in Sarcoidosis) project represents a European multicentre study to investigate the influence of genotype on disease phenotypes in sarcoidosis.The baseline phenotype module of GenPhenReSa comprised 2163 Caucasian patients with sarcoidosis who were phenotyped at 31 study centres according to a standardised protocol.From this module, we found that patients with acute onset were mainly female, young and of Scadding type I or II. Female patients showed a significantly higher frequency of eye and skin involvement, and complained more of fatigue. Based on multidimensional correspondence analysis and subsequent cluster analysis, patients could be clearly stratified into five distinct, yet undescribed, subgroups according to predominant organ involvement: 1) abdominal organ involvement, 2) ocular–cardiac–cutaneous–central nervous system disease involvement, 3) musculoskeletal–cutaneous involvement, 4) pulmonary and intrathoracic lymph node involvement, and 5) extrapulmonary involvement.These five new clinical phenotypes will be useful to recruit homogenous cohorts in future biomedical studies.
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Reference44 articles.
1. Statement on Sarcoidosis
2. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
3. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis – results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft für die Therapie von Lungenkrankheitan;Loddenkemper;Sarcoidosis Vasc Diffuse Lung Dis,1998
4. GLOBAL EPIDEMIOLOGY OF SARCOIDOSIS
5. Epidemiology of sarcoidosis in Japan